Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Microbial Changes of Intranasal Neosporin
NCT07698938Completed
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Feb 2025
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial of bacitracin + neomycin + polymyxin B in bacterial infection, sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Primary endpoint: Adverse events of intranasal Neosporin at 16 days. Started Feb 2025; status: completed.
02
Drugs
bacitracin + neomycin + polymyxin B
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT07698938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07698938.